{
    "root": "3493e7f3-c477-ba3e-e063-6394a90a1c31",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Minocycline Hydrochloride",
    "value": "20250507",
    "ingredients": [
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "MINOCYCLINE HYDROCHLORIDE",
            "code": "0020414E5U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50697"
        }
    ],
    "indications": {
        "text": "minocycline hydrochloride capsules , usp indicated treatment following infections due susceptible strains designated microorganisms : rocky mountain spotted fever , typhus fever typhus group , q fever , rickettsialpox tick fevers caused rickettsiae . respiratory tract infections caused mycoplasma pneumoniae . lymphogranuloma venereum caused chlamydia trachomatis . psittacosis ( ornithosis ) due chlamydophila psittaci . trachoma caused chlamydia trachomatis , although infectious agent always eliminated , judged immunofluorescence . inclusion conjunctivitis caused chlamydia trachomatis . nongonococcal urethritis , endocervical , rectal infections adults caused ureaplasma urealyticum chlamydia trachomatis . relapsing fever due borrelia recurrentis . chancroid caused haemophilus ducreyi . plague due yersinia pestis . tularemia due francisella tularensis . cholera caused vibrio cholerae . campylobacter fetus infections caused campylobacter fetus . brucellosis due brucella species ( conjunction streptomycin ) . bartonellosis due bartonella bacilliformis . granuloma inguinale caused klebsiella granulomatis . minocycline indicated treatment infections caused following gram-negative microorganisms bacteriologic testing indicates appropriate susceptibility : escherichia coli . enterobacter aerogenes . shigella species . acinetobacter species . respiratory tract infections caused haemophilus influenzae . respiratory tract urinary tract infections caused klebsiella species . minocycline hydrochloride capsules , usp indicated treatment infections caused following gram-positive microorganisms bacteriologic testing indicates appropriate susceptibility : upper respiratory tract infections caused streptococcus pneumoniae . skin skin structure infections caused staphylococcus aureus ( note : minocycline choice treatment type staphylococcal infection ) . penicillin contraindicated , minocycline alternative treatment following infections : uncomplicated urethritis men due neisseria gonorrhoeae treatment gonococcal infections . infections women caused neisseria gonorrhoeae . syphilis caused treponema pallidum subspecies pallidum . yaws caused treponema pallidum subspecies pertenue . listeriosis due listeria monocytogenes . anthrax due bacillus anthracis . vincent 's infection caused fusobacterium fusiforme . actinomycosis caused actinomyces israelii . infections caused clostridium species . acute intestinal amebiasis , minocycline may useful adjunct amebicides . severe acne , minocycline may useful adjunctive therapy . oral minocycline indicated treatment asymptomatic carriers neisseria meningitidis eliminate meningococci nasopharynx . order preserve usefulness minocycline treatment asymptomatic meningococcal carriers , diagnostic laboratory procedures , including serotyping susceptibility testing , performed establish carrier state correct treatment . recommended prophylactic minocycline reserved situations risk meningococcal meningitis high . oral minocycline indicated treatment meningococcal infection . although controlled efficacy conducted , limited data show oral minocycline hydrochloride used successfully treatment infections caused mycobacterium marinum . reduce development drug-resistant bacteria maintain effectiveness minocycline hydrochloride capsules , usp antibacterial drugs , minocycline hydrochloride capsules , usp used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy .",
        "doid_entities": [
            {
                "text": "rocky mountain spotted fever (DOID:0050052)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050052"
            },
            {
                "text": "spotted fever (DOID:11104)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11104"
            },
            {
                "text": "typhus (DOID:11256)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11256"
            },
            {
                "text": "q fever (DOID:11100)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11100"
            },
            {
                "text": "rickettsialpox (DOID:11103)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11103"
            },
            {
                "text": "lymphogranuloma venereum (DOID:13819)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13819"
            },
            {
                "text": "chlamydia (DOID:11263)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11263"
            },
            {
                "text": "psittacosis (DOID:11262)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11262"
            },
            {
                "text": "trachoma (DOID:11265)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11265"
            },
            {
                "text": "inclusion conjunctivitis (DOID:13800)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13800"
            },
            {
                "text": "conjunctivitis (DOID:6195)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6195"
            },
            {
                "text": "nongonococcal urethritis (DOID:1343)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1343"
            },
            {
                "text": "relapsing fever (DOID:13034)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13034"
            },
            {
                "text": "chancroid (DOID:13778)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13778"
            },
            {
                "text": "plague (DOID:3482)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3482"
            },
            {
                "text": "tularemia (DOID:2123)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2123"
            },
            {
                "text": "cholera (DOID:1498)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1498"
            },
            {
                "text": "brucellosis (DOID:11077)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11077"
            },
            {
                "text": "bartonellosis (DOID:11102)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11102"
            },
            {
                "text": "granuloma inguinale (DOID:9113)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9113"
            },
            {
                "text": "syphilis (DOID:4166)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4166"
            },
            {
                "text": "yaws (DOID:10371)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10371"
            },
            {
                "text": "listeriosis (DOID:11573)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11573"
            },
            {
                "text": "actinomycosis (DOID:8478)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8478"
            },
            {
                "text": "amebiasis (DOID:9181)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9181"
            },
            {
                "text": "acne (DOID:6543)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6543"
            },
            {
                "text": "meningococcal meningitis (DOID:0080176)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080176"
            },
            {
                "text": "meningitis (DOID:9471)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9471"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute intestinal amebiasis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_2300"
            }
        ]
    },
    "contraindications": null,
    "warningsAndPrecautions": "minocycline hcl capsules , usp equivalent 100 mg * minocycline gray opaque cap white opaque body imprinted `` rx 696 `` cap body black ink supplied follows : ndc 68071-2866-2 bottles 20 ndc 68071-2866-6 bottles 60 ndc 68071-2866-8 bottles 28 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . protect light , moisture excessive heat . dispense tight , light-resistant container child-resistant closure . * appearance product may vary depending source ingredients filled capsule . animal pharmacology toxicology minocycline hydrochloride observed cause dark discoloration thyroid experimental animals ( rats , minipigs , dogs , monkeys ) . rat , chronic treatment minocycline hydrochloride resulted goiter accompanied elevated radioactive iodine uptake evidence thyroid tumor production . minocycline hydrochloride also found produce thyroid hyperplasia rats dogs .",
    "adverseReactions": "contraindicated persons shown hypersensitivity tetracyclines components product formulation .",
    "indications_original": "Minocycline hydrochloride capsules, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms:\n                  Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae.\n                  Respiratory tract infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Mycoplasma pneumoniae.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Lymphogranuloma venereum caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Chlamydia trachomatis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Psittacosis (Ornithosis) due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Chlamydophila psittaci.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Trachoma caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Inclusion conjunctivitis caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Chlamydia trachomatis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Nongonococcal urethritis, endocervical, or rectal infections in adults caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Ureaplasma urealyticum or \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Chlamydia trachomatis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Relapsing fever due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Borrelia recurrentis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Chancroid caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Haemophilus ducreyi.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Plague due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Yersinia pestis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Tularemia due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Francisella tularensis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Cholera caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Vibrio cholerae.\n                  \n                  Campylobacter fetus infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Campylobacter fetus.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Brucellosis due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Brucella species (in conjunction with streptomycin). \n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Bartonellosis due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Bartonella bacilliformis.\n                  \n                  Granuloma inguinale caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Klebsiella\n                      granulomatis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  \n                     Escherichia coli.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  \n                     Enterobacter aerogenes.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  \n                     Shigella species.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  \n                     Acinetobacter species.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Respiratory tract infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Haemophilus influenzae.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Respiratory tract and urinary tract infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Klebsiella species.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Minocycline hydrochloride capsules, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  Upper respiratory tract infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Streptococcus pneumoniae.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Skin and skin structure infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Staphylococcus aureus (Note: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection).\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections:\n                  Uncomplicated urethritis in men due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Neisseria gonorrhoeae and for the treatment of other gonococcal infections.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Infections in women caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Neisseria gonorrhoeae.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Syphilis caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Treponema pallidum subspecies \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  pallidum.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Yaws caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Treponema pallidum subspecies \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  pertenue.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Listeriosis due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Listeria monocytogenes.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Anthrax due to \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Bacillus anthracis.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Vincent's infection caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Fusobacterium fusiforme.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Actinomycosis caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Actinomyces israelii.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  \u00a0Infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Clostridium species.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  In \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  In severe \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  acne, minocycline may be useful adjunctive therapy.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Oral minocycline is indicated in the treatment of asymptomatic carriers of \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  \n                     Oral minocycline is not indicated for the treatment of meningococcal infection.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by \n       \n \n  \n       \n \n  \n       \n \n  \n       \n \n  Mycobacterium marinum.\n      \n\n \n      \n\n \n      \n\n \n      \n\n \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride capsules, USP and other antibacterial drugs, minocycline hydrochloride capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "warningsAndPrecautions_original": "Minocycline HCl Capsules, USP equivalent to 100 mg* minocycline with a gray opaque cap and white opaque body imprinted \" \n  RX 696\" on cap and body in black ink and supplied as follows:\n \n                  NDC 68071-2866-2 BOTTLES OF 20\n                  NDC 68071-2866-6 BOTTLES OF 60\n                  NDC 68071-2866-8 BOTTLES OF 28\n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  \n                     Protect from light, moisture and excessive heat.\n                  \n                  \n                     Dispense in a tight, light-resistant container with child-resistant closure.\n                  \n                  * The appearance of the product may vary depending on the source of the ingredients filled in the capsule.\n                  \n                     ANIMAL PHARMACOLOGY AND TOXICOLOGY\n                  \n                  Minocycline hydrochloride has been observed to cause a dark discoloration of the thyroid in experimental animals (rats, minipigs, dogs, and monkeys). In the rat, chronic treatment with minocycline hydrochloride has resulted in goiter accompanied by elevated radioactive iodine uptake and evidence of thyroid tumor production. Minocycline hydrochloride has also been found to produce thyroid hyperplasia in rats and dogs.",
    "adverseReactions_original": "This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or to any of the components of the product formulation.",
    "drug": [
        {
            "name": "Minocycline Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50697"
        }
    ]
}